SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-040169
Filing Date
2017-06-19
Accepted
2017-06-19 16:07:03
Documents
3
Period of Report
2017-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-15400_18k.htm 8-K 29159
2 EX-99.1 a17-15400_1ex99d1.htm EX-99.1 11437
3 GRAPHIC g154001mmi001.jpg GRAPHIC 2594
  Complete submission text file 0001104659-17-040169.txt   45556
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 17918593
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1